UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Clinical cancer research, 2023-08, Vol.29 (16), p.2979-2987

2023

Volltextzugriff (PDF)

Contribution of airway eosinophils in airway wall remodeling in asthma: Role of MMP‐10 and MET

Allergy (Copenhagen), 2019-06, Vol.74 (6), p.1102-1112

2019

Volltextzugriff (PDF)

Consolidation treatment of durvalumab after chemoradiation in real‐world patients with stage III unresectable non‐small cell lung cancer

Thoracic cancer, 2020-06, Vol.11 (6), p.1541-1549

2020

Volltextzugriff (PDF)

T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED

The European respiratory journal, 2017-02, Vol.49 (2), p.1602135-1602135

2017

Volltextzugriff (PDF)

Sputum transcriptomics reveal upregulation of IL-1 receptor family members in patients with severe asthma

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.560-570

2018

Volltextzugriff (PDF)

Afatinib treatment in a large real‐world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation

International journal of cancer, 2022-02, Vol.150 (4), p.626-635

2022

Volltextzugriff (PDF)

A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED

American journal of respiratory and critical care medicine, 2017-02, Vol.195 (4), p.443-455

2017

Volltextzugriff (PDF)

Lung Cancer in Republic of China

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.519-527

2021

Volltextzugriff (PDF)

Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD

Thorax, 2023-04, Vol.78 (4), p.335

2023

Volltextzugriff (PDF)

Metabolic re-patterning in COPD airway smooth muscle cells

The European respiratory journal, 2017-11, Vol.50 (5), p.1700202-1700202

2017

Volltextzugriff (PDF)

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis

Scientific reports, 2022-03, Vol.12 (1), p.4398-4398, Article 4398

2022

Volltextzugriff (PDF)

Trastuzumab Deruxtecan in Patients With HER2 -Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial

Journal of clinical oncology, 2023-11, Vol.41 (31), p.4852

2023

Volltextzugriff (PDF)

Thrombin worsens extravascular lung water and outcomes of septic patients with acute respiratory distress syndrome: A case control study

Medicine (Baltimore), 2023-12, Vol.102 (48), p.e36200-e36200

2023

Volltextzugriff (PDF)

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

BMC cancer, 2021-07, Vol.21 (1), p.1-859, Article 859

2021

Volltextzugriff (PDF)

Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma

Cancers, 2022-01, Vol.14 (3), p.674

2022

Volltextzugriff (PDF)

Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer

Thoracic cancer, 2024-03, Vol.15 (7), p.529-537

2024

Volltextzugriff (PDF)

DNA methylation modules in airway smooth muscle are associated with asthma severity

The European respiratory journal, 2018-04, Vol.51 (4), p.1701068-1701068

2018

Volltextzugriff (PDF)

Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer

International journal of cancer, 2012-08, Vol.131 (3), p.E227-E235

2012

Volltextzugriff (PDF)

Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan

Thoracic cancer, 2023-01, Vol.14 (1), p.12-23

2023

Volltextzugriff (PDF)

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Scientific reports, 2023-11, Vol.13 (1), p.20323-20323, Article 20323

2023

Volltextzugriff (PDF)

Bevacizumab Reduces S100A9-Positive MDSCs Linked to Intracranial Control in Patients with EGFR-Mutant Lung Adenocarcinoma

Journal of thoracic oncology, 2018-07, Vol.13 (7), p.958-967

2018

Volltextzugriff (PDF)

Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients

Thoracic cancer, 2022-07, Vol.13 (13), p.1888-1897

2022

Volltextzugriff (PDF)

Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations

Therapeutic advances in respiratory disease, 2022, Vol.16, p.175346662211327-17534666221132731

2022

Volltextzugriff (PDF)

Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study

Environmental health, 2024-03, Vol.23 (1), p.29-29, Article 29

2024

Volltextzugriff (PDF)

Factors Influencing Posttraumatic Growth Among Primary Caregivers of Patients with Oncologic Emergencies in Taiwan Intensive Care Units: A Cross-Sectional Study of Patient–Caregiver Dyads

Seminars in oncology nursing, 2023-10, Vol.39 (5), p.151497-151497, Article 151497

2023

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(108)
Berichte
(3)

Sprache

Englisch
(110)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

Contribution of airway eosinophils in airway wall remodeling in asthma: Role of MMP‐10 and MET

Consolidation treatment of durvalumab after chemoradiation in real‐world patients with stage III unresectable non‐small cell lung cancer

T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED

Sputum transcriptomics reveal upregulation of IL-1 receptor family members in patients with severe asthma

Afatinib treatment in a large real‐world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation

A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED

Lung Cancer in Republic of China

Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD

Metabolic re-patterning in COPD airway smooth muscle cells

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis

Trastuzumab Deruxtecan in Patients With HER2 -Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial

Thrombin worsens extravascular lung water and outcomes of septic patients with acute respiratory distress syndrome: A case control study

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma

Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer

DNA methylation modules in airway smooth muscle are associated with asthma severity

Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer

Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Bevacizumab Reduces S100A9-Positive MDSCs Linked to Intracranial Control in Patients with EGFR-Mutant Lung Adenocarcinoma

Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients

Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations

Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study

Factors Influencing Posttraumatic Growth Among Primary Caregivers of Patients with Oncologic Emergencies in Taiwan Intensive Care Units: A Cross-Sectional Study of Patient–Caregiver Dyads

Suchergebnisse filtern